Anticoagulation and other risk factors for clinically relevant bleeding after medical hospitalization: the Medical Inpatient Thrombosis and Hemostasis Study

IF 5 2区 医学 Q1 HEMATOLOGY Journal of Thrombosis and Haemostasis Pub Date : 2025-07-01 Epub Date: 2025-03-21 DOI:10.1016/j.jtha.2025.02.044
Mansour Gergi , Katherine Wilkinson , Andrew Sparks , Nicholas S. Roetker , Hanny Al-Samkari , Nicholas L. Smith , Timothy B. Plante , Mary Cushman , Allen B. Repp , Chris E. Holmes , Karlyn Martin , Neil A. Zakai
{"title":"Anticoagulation and other risk factors for clinically relevant bleeding after medical hospitalization: the Medical Inpatient Thrombosis and Hemostasis Study","authors":"Mansour Gergi ,&nbsp;Katherine Wilkinson ,&nbsp;Andrew Sparks ,&nbsp;Nicholas S. Roetker ,&nbsp;Hanny Al-Samkari ,&nbsp;Nicholas L. Smith ,&nbsp;Timothy B. Plante ,&nbsp;Mary Cushman ,&nbsp;Allen B. Repp ,&nbsp;Chris E. Holmes ,&nbsp;Karlyn Martin ,&nbsp;Neil A. Zakai","doi":"10.1016/j.jtha.2025.02.044","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Clinically relevant bleeding after discharge from a medical hospitalization is associated with increased morbidity and mortality. There is limited knowledge of the risk factors for this bleeding.</div></div><div><h3>Objectives</h3><div>We aimed to determine the risk factors for bleeding leading to rehospitalization after hospital discharge.</div></div><div><h3>Methods</h3><div>The study population consisted of primary care patients followed longitudinally from October 2010 to September 2019 for medical hospitalization and clinically relevant bleeding. People discharged alive from a medical hospitalization were followed for up to 90 days for postdischarge bleeding requiring rehospitalization. Age-, sex- (male vs female), and length of stay–adjusted hazard ratios for candidate bleeding risk factors were estimated using Cox proportional hazards models.</div></div><div><h3>Results</h3><div>Over 9 years, there were 15 630 medical hospitalization discharges and 414 (2.6%) postdischarge clinically relevant bleeding events that required readmission. Clinical and patient factors related to the postdischarge bleeding risk were increasing age, active cancer, liver disease, creatinine concentration of &gt;2 g/dL, heart disease, and history of previous gastrointestinal or central nervous system bleeding. Hemoglobin concentrations of &lt;12 g/dL for women and &lt;13.6 g/dL for men, a platelet count of &lt;50 × 10<sup>3</sup> mm<sup>3</sup>, and anticoagulation at discharge were also associated with an increased risk for clinically relevant bleeding postdischarge.</div></div><div><h3>Conclusion</h3><div>Postdischarge bleeding requiring hospitalization occurs in 2.6% of medical hospitalizations and has objective and readily identifiable risk factors. Findings suggest that clinically relevant bleeding postdischarge may be predictable and quantifiable, which could help increase the safety of anticoagulation decisions at discharge.</div></div>","PeriodicalId":17326,"journal":{"name":"Journal of Thrombosis and Haemostasis","volume":"23 7","pages":"Pages 2122-2132"},"PeriodicalIF":5.0000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Thrombosis and Haemostasis","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1538783625001862","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/21 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Clinically relevant bleeding after discharge from a medical hospitalization is associated with increased morbidity and mortality. There is limited knowledge of the risk factors for this bleeding.

Objectives

We aimed to determine the risk factors for bleeding leading to rehospitalization after hospital discharge.

Methods

The study population consisted of primary care patients followed longitudinally from October 2010 to September 2019 for medical hospitalization and clinically relevant bleeding. People discharged alive from a medical hospitalization were followed for up to 90 days for postdischarge bleeding requiring rehospitalization. Age-, sex- (male vs female), and length of stay–adjusted hazard ratios for candidate bleeding risk factors were estimated using Cox proportional hazards models.

Results

Over 9 years, there were 15 630 medical hospitalization discharges and 414 (2.6%) postdischarge clinically relevant bleeding events that required readmission. Clinical and patient factors related to the postdischarge bleeding risk were increasing age, active cancer, liver disease, creatinine concentration of >2 g/dL, heart disease, and history of previous gastrointestinal or central nervous system bleeding. Hemoglobin concentrations of <12 g/dL for women and <13.6 g/dL for men, a platelet count of <50 × 103 mm3, and anticoagulation at discharge were also associated with an increased risk for clinically relevant bleeding postdischarge.

Conclusion

Postdischarge bleeding requiring hospitalization occurs in 2.6% of medical hospitalizations and has objective and readily identifiable risk factors. Findings suggest that clinically relevant bleeding postdischarge may be predictable and quantifiable, which could help increase the safety of anticoagulation decisions at discharge.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
住院后抗凝和其他危险因素导致临床相关出血:住院患者血栓和止血研究
临床相关的出血从医疗住院出院后与发病率和死亡率增加有关。对这种出血的危险因素了解有限。目的:探讨出血导致出院后再住院的危险因素。方法:研究人群包括2010年10月至2019年9月期间住院治疗和临床相关出血的初级保健患者。对于出院后出血需要再次住院的患者,研究人员对其进行了长达90天的随访。使用Cox比例风险模型估计候选出血危险因素的年龄、性别和住院时间调整后的风险比(HR)。结果:9年间,15630例内科住院出院,414例(2.6%)出院后临床相关出血需要再次入院。与出院后出血风险相关的临床和患者因素为年龄增加、活动性癌症、肝病、肌酐bbb20 g/dl、心脏病、既往胃肠道或中枢神经系统出血史。血红蛋白3mm3和出院时抗凝也与出院后临床相关出血的风险增加有关。结论:2.6%的内科住院患者发生再次出血,且存在客观且易于识别的危险因素。研究结果表明,出院后临床相关出血可以预测和量化,这有助于提高出院时抗凝决策的安全性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis 医学-外周血管病
CiteScore
24.30
自引率
3.80%
发文量
321
审稿时长
1 months
期刊介绍: The Journal of Thrombosis and Haemostasis (JTH) serves as the official journal of the International Society on Thrombosis and Haemostasis. It is dedicated to advancing science related to thrombosis, bleeding disorders, and vascular biology through the dissemination and exchange of information and ideas within the global research community. Types of Publications: The journal publishes a variety of content, including: Original research reports State-of-the-art reviews Brief reports Case reports Invited commentaries on publications in the Journal Forum articles Correspondence Announcements Scope of Contributions: Editors invite contributions from both fundamental and clinical domains. These include: Basic manuscripts on blood coagulation and fibrinolysis Studies on proteins and reactions related to thrombosis and haemostasis Research on blood platelets and their interactions with other biological systems, such as the vessel wall, blood cells, and invading organisms Clinical manuscripts covering various topics including venous thrombosis, arterial disease, hemophilia, bleeding disorders, and platelet diseases Clinical manuscripts may encompass etiology, diagnostics, prognosis, prevention, and treatment strategies.
期刊最新文献
Effects of continuation versus interruption of oral anticoagulation during transcatheter aortic valve implantation on hemostasis function Plasma proteomics does not identify biomarkers of venous thromboembolism recurrence during and after anticoagulation: results from the VISTA study Comparative analysis of radiation exposure from computed tomography and ventilation-perfusion scans in the diagnosis of pulmonary embolism: an early-onset cancer risk assessment Right ventricular dysfunction on echocardiography to predict mortality in acute pulmonary embolism: an individual patient data meta-analysis Postthrombotic syndrome-related chronic limb pain in children: findings from the Multicenter Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1